ADAM17 and colon carcinoma: These include ADAM17, BIRC2 and VANGL1. ADAM17 has been reported up-regulated in colon carcinomas and has been shown to promote the release of epidermal growth factor receptor (EGFR) ligands from the cell membrane, thus activating EGFR [46].